Clinical and laboratory features of patients diagnosed with alpha‐gal syndrome—2010–2019
Allergy · 2023-02 · 78 (2) · 477-487
DOI: 10.1111/all.15539 ↗At a glance
Journal article in Allergy, published online on 2022-10-14. Written by Alison M Binder and 9 co-authors. Institution: Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA. Major MEDLINE topics: Anaphylaxis, Tick Bites, Food Hypersensitivity. Cited 46 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Centers for Disease Control and Prevention, University of North Carolina.
Abstract (original language)
Background
Alpha‐gal syndrome (AGS) is an IgE‐mediated allergy to galactose‐alpha‐1,3‐galactose. Clinical presentation ranges from hives to anaphylaxis; episodes typically occur 2–6 h after exposure to alpha‐gal‐containing products. In the United States, lone star tick bites are associated with the development of AGS. To characterize features of AGS, we evaluated a cohort of patients presenting for care at the University of North Carolina, focusing on symptoms, severity, and identifying features unique to specific alpha‐gal‐containing product exposures.
Methods
We performed a chart review and descriptive analysis of 100 randomly selected patients with AGS during 2010–2019.
Results
Median age at onset was 53 years, 56% were female, 95% reported White race, 86% reported a history of tick bite, and 75% met the criteria for anaphylaxis based on the involvement of ≥2 organ systems. Those reporting dairy reactions were significantly less likely to report isolated mucocutaneous symptoms (3% vs. 24%; ratio [95% CI]: 0.1 [0.1, 0.3]) than those who tolerated dairy, and were more likely to report gastrointestinal symptoms (79% vs. 59%; ratio [95% CI]: 1.3 [0.7, 2.6]), although this difference was not statistically significant. Dairy‐tolerant patients demonstrated higher alpha‐gal sIgE titers (as a percentage of total IgE) than dairy‐reactive patients (GM 4.1 [95% CI: 2.7, 6.1] vs. GM 2.5 [95% CI: 1.3, 4.8], respectively; ratio −1.6 [95% CI: −1.0, 3.9]).
Conclusion
While tick exposure is common in the southern United States, nearly all AGS patients reported a tick bite. Gastrointestinal symptoms were prominent among those reporting reactions to dairy. Anaphylaxis was common, underscoring the severity and need to raise awareness of AGS among patients and providers.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
- University of North Carolina, Chapel Hill, North Carolina, USA.
ORCID profiles: Alison M Binder, Dena Cherry-Brown, Scott P Commins
Funding
- Centers for Disease Control and Prevention
- University of North Carolina
Cite
APA
Binder, A. M., Cherry-Brown, D., Biggerstaff, B. J., Jones, E. S., Amelio, C. L., Beard, C. B., Petersen, L. R., Kersh, G. J., Commins, S. P., & Armstrong, P. A. (2023). Clinical and laboratory features of patients diagnosed with alpha‐gal syndrome—2010–2019. Allergy, 78(2), 477-487. https://doi.org/10.1111/all.15539
Vancouver
Binder AM, Cherry-Brown D, Biggerstaff BJ, Jones ES, Amelio CL, Beard CB, et al. Clinical and laboratory features of patients diagnosed with alpha‐gal syndrome—2010–2019. Allergy. 2023;78(2):477-487. doi:10.1111/all.15539
BibTeX
@article{Binder2023,
author = {Binder, Alison M and Cherry-Brown, Dena and Biggerstaff, Brad J and Jones, Emma S and Amelio, Claire L and Beard, Charles B and Petersen, Lyle R and Kersh, Gilbert J and Commins, Scott P and Armstrong, Paige A},
title = {Clinical and laboratory features of patients diagnosed with alpha‐gal syndrome—2010–2019},
journal = {Allergy},
year = {2023},
volume = {78},
number = {2},
pages = {477--487},
doi = {10.1111/all.15539}
}
EUVIMED